...Great. Well, good afternoon, everyone. Thanks so much for joining us for our first afternoon session. My name is Nathan Rich, I cover the generic pharma space for Goldman Sachs. Very pleased to have Viatris up here with us. I'll do some quick introductions and then we can jump into the Q&A. So to my right, Scott Smith, new Chief Executive Officer; in the center, Rajiv Malik, President; and Sanjeev Narula, CFO. So thank you guys for joining us. Really appreciate you being here. Scott Andrew Smith ...